The UK government has announced an expansion of the Transform trial with £18 million in funding to invite additional black men aged 45-74 for prostate cancer screening. Supported facts include annual UK diagnosis and mortality figures plus lifetime risk differences by demographic. Scope of invitations and exact eligibility criteria remain disputed between reports.